Resmed Inc. buy UBS Group AG
Start price
22.05.23
/
50%
€210.60
Target price
22.05.24
-
Performance (%)
-3.75%
End price
23.05.24
€202.70
Summary
This prediction ended on 23.05.24 with a price of €202.70. With a performance of -3.75%, the BUY prediction for Resmed Inc. by UBS_Group_AG closed slightly in the red. Dividends of €1.78 are taken into consideration when calculating the performance. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | -2.233% | -2.233% | -11.588% |
| iShares Core DAX® | 1.133% | -0.156% | 14.356% |
| iShares Nasdaq 100 | 0.815% | 8.801% | 34.123% |
| iShares Nikkei 225® | 1.990% | 3.286% | 10.759% |
| iShares S&P 500 | -0.014% | 5.438% | 26.681% |
Comments by UBS_Group_AG for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten